Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? J Clin Oncol. 2007 Feb 20; 25(6):611-3.
View in:
PubMed
subject areas
Aged
Antibodies, Monoclonal
Antineoplastic Agents
Breast Neoplasms
Chemotherapy, Adjuvant
Cost of Illness
Cost-Benefit Analysis
Drug Costs
Humans
Male
Middle Aged
Prognosis
Survival Analysis
United States
authors with profiles
Thomas Jay Smith, Ph.D.